Covert Cerebral Small Vessel Disease: Ready for Clinical Prime Time.

Covert Cerebral Small Vessel Disease: Ready for Clinical Prime Time.
复制标题

隐性脑小血管疾病:为临床黄金时间做好准备。

DOI:
10.1161/jaha.123.029891
复制
发表时间:
2023
影响因子:
5.4
通讯作者:
Romero,JoseRafael
Romero,JoseRafael
中科院分区:
医学2区
文献类型:
--
作者:
Hannawi,Yousef;Vaishnav,Anand;Coskun,ElifPinar;Gangadhara,Suhas;Romero,JoseRafael

文献摘要

相似文献

2023年1月,美国心脏协会和美国中风协会在2023年2月举行的国际中风会议上提出了实施大脑日期的想法。这个想法是为了促进关于可以促进中风治疗的话题的讨论,同时促进网络和合作。冠军们被邀请以不同的形式领导这样的小组。成立了一个小组,就隐蔽(亚临床)脑血管疾病(cSVD)患者的临床护理现状进行公开讨论,包括筛查、预防和管理这些患者,同时关注资源有限的国家。该小组包括5名从不同角度探讨这一主题的与会者:一名正在接受培训的神经内科住院医师,一名职业生涯早期的血管神经学家,一名在资源有限的国家执业的经验丰富的临床医生,一名在具有心血管疾病专业知识的学术机构从事中风和神经危重症护理的临床医生兼科学家和部门主任,以及一名已建立的临床医生和中风中心主任。由于目前缺乏高质量的证据来支持我们讨论中提出的问题的具体建议,因此本文提出的结论主要旨在提高认识,促进认识,并刺激未来的研究,以解决目前在隐蔽性cSVD的筛查,预防和管理方面的知识差距。
In January 2023, the American Heart Association and American Stroke Association introduced the idea of implementing a brain date during the International Stroke Conference held in February 2023. The idea was to foster discussion about topics that could advance stroke care while fomenting networking and collaborations. Champions were invited to lead such groups with different formats. A group was formed for an open discussion about the current state of clinical care for patients with covert (subclinical) cerebral small vessel disease (cSVD) including screening, prevention, and management of these patients while paying attention to countries with limited resources. The group included 5 attendees approaching this topic from different perspectives: a neurology physician–resident in training, an early career vascular neurologist, a seasoned clinician practicing at a country in a context of limited resources, a clinician–scientist and division director of stroke and neurocritical care at an academic institution with expertise in cSVD, and an established clinician and a director of a stroke center. Because high-quality evidence is currently lacking to support specific recommendations on the questions posed in our discussion, the conclusions presented in this article primarily aim to increase awareness, promote recognition, and stimulate future research to address the current knowledge gaps in screening, prevention, and management of covert cSVD.